EUVIMEDAtklāt EUVIMED
Crossref

2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency

Alison Knopf

The Brown University Child & Adolescent Psychopharmacology Update · 2026-04 · 28 (4) · 7-7

DOI: 10.1002/cpu.31055 ↗

At a glance

Journal article in The Brown University Child & Adolescent Psychopharmacology Update, published online on 2026-03-23. Written by Alison Knopf.

AbstraktsBibliogrāfiskie datiCiteRelated studies

Abstract (original language)

Kopsavilkums nav pieejams.

Cite

APA

Knopf, A. (2026). 2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency. The Brown University Child & Adolescent Psychopharmacology Update, 28(4), 7-7. https://doi.org/10.1002/cpu.31055

Vancouver

Knopf A. 2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency. The Brown University Child & Adolescent Psychopharmacology Update. 2026;28(4):7-7. doi:10.1002/cpu.31055

BibTeX
@article{Knopf2026,
  author = {Knopf, Alison},
  title = {2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency},
  journal = {The Brown University Child & Adolescent Psychopharmacology Update},
  year = {2026},
  volume = {28},
  number = {4},
  pages = {7--7},
  doi = {10.1002/cpu.31055}
}
Start for free →